Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Curley

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Pharmaceutical Research|June 1, 1999
NMR studies of retinoid-protein interactions: the conformation of [13C]-beta-ionones bound to beta-lactoglobulin BR W Curley, A K Sundaram, J W Fowble, et al.
Bioorganic & Medicinal Chemistry|January 18, 2006
Synthesis and preliminary chemotherapeutic evaluation of the fully C-linked glucuronide of N-(4-hydroxyphenyl)retinamideJoel R Walker, Galal Alshafie, Nirca Nieves, et al.
Anticancer Research|December 31, 1997
Chemotherapeutic evaluation of N-(4-hydroxyphenyl) retinamide-O-glucuronide in the rat mammary tumor modelH Abou-Issa, R W Curley, M J Panigot, et al.
Anticancer Research|April 5, 2017
Differential Effect of Wortmannolone Derivatives on MDA-MB-231 Breast Cancer CellsUlyana Munoz Acuña, Robert W Curley, Nighat Fatima, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2006
Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogsSerena M Mershon, Allyson L Anding, Jason S Chapman, et al.
Chemical Research in Toxicology|September 24, 2011
4-Hydroxybenzyl modification of the highly teratogenic retinoid, 4-[(1E)-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)-1-propen-1-yl]benzoic acid (TTNPB), yields a compound that induces apoptosis in breast cancer cells and shows reduced teratogenicityAllyson L Anding, Nirca J Nieves, Victoria V Abzianidze, et al.
Cancer Research|March 17, 2006
4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell linesMaria Grazia Villani, Valentina Appierto, Elena Cavadini, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
An unhydrolyzable analogue of N-(4-hydroxyphenyl)retinamide. synthesis and preliminary biological studiesK L Weiss, G Alshafie, J S Chapman, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 18, 2016
An HPLC-MS/MS method for the separation of α-retinyl esters from retinyl estersHilary J Goetz, Rachel E Kopec, Ken M Riedl, et al.
Anticancer Research|March 26, 2002
Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesisH Abou-Issa, R W Curley, G A Alshafie, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Pharmaceutical Research|June 1, 1999
NMR studies of retinoid-protein interactions: the conformation of [13C]-beta-ionones bound to beta-lactoglobulin BR W Curley, A K Sundaram, J W Fowble, et al.
Bioorganic & Medicinal Chemistry|January 18, 2006
Synthesis and preliminary chemotherapeutic evaluation of the fully C-linked glucuronide of N-(4-hydroxyphenyl)retinamideJoel R Walker, Galal Alshafie, Nirca Nieves, et al.
Anticancer Research|December 31, 1997
Chemotherapeutic evaluation of N-(4-hydroxyphenyl) retinamide-O-glucuronide in the rat mammary tumor modelH Abou-Issa, R W Curley, M J Panigot, et al.
Anticancer Research|April 5, 2017
Differential Effect of Wortmannolone Derivatives on MDA-MB-231 Breast Cancer CellsUlyana Munoz Acuña, Robert W Curley, Nighat Fatima, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2006
Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogsSerena M Mershon, Allyson L Anding, Jason S Chapman, et al.
Chemical Research in Toxicology|September 24, 2011
4-Hydroxybenzyl modification of the highly teratogenic retinoid, 4-[(1E)-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)-1-propen-1-yl]benzoic acid (TTNPB), yields a compound that induces apoptosis in breast cancer cells and shows reduced teratogenicityAllyson L Anding, Nirca J Nieves, Victoria V Abzianidze, et al.
Cancer Research|March 17, 2006
4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell linesMaria Grazia Villani, Valentina Appierto, Elena Cavadini, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
An unhydrolyzable analogue of N-(4-hydroxyphenyl)retinamide. synthesis and preliminary biological studiesK L Weiss, G Alshafie, J S Chapman, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 18, 2016
An HPLC-MS/MS method for the separation of α-retinyl esters from retinyl estersHilary J Goetz, Rachel E Kopec, Ken M Riedl, et al.
Anticancer Research|March 26, 2002
Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesisH Abou-Issa, R W Curley, G A Alshafie, et al.
Pageof 10